Geoffrey A. Swire
Directeur des opérations chez ALLENA PHARMACEUTICALS, INC.
Postes actifs de Geoffrey A. Swire
Sociétés | Poste | Début | Fin |
---|---|---|---|
ALLENA PHARMACEUTICALS, INC. | Directeur des opérations | 10/11/2020 | - |
Corporate Officer/Principal | 01/01/2018 | - |
Historique de carrière de Geoffrey A. Swire
Anciens postes connus de Geoffrey A. Swire
Sociétés | Poste | Début | Fin |
---|---|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - | - |
RADIUS HEALTH, INC. | Corporate Officer/Principal | - | - |
Formation de Geoffrey A. Swire
Dartmouth College | Undergraduate Degree |
Harvard University | Graduate Degree |
Statistiques
Internationale
Etats-Unis | 6 |
Opérationnelle
Corporate Officer/Principal | 3 |
Undergraduate Degree | 1 |
Chief Operating Officer | 1 |
Sectorielle
Health Technology | 4 |
Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
ALLENA PHARMACEUTICALS, INC. | Health Technology |
Entreprise privées | 2 |
---|---|
Radius Health, Inc.
Radius Health, Inc. BiotechnologyHealth Technology Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company’s lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also includes the abaloparatide transdermal patch for potential use in osteoporosis, and RAD1901 for potential use in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal women. The company was founded by John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt, and John T. Potts on October 3, 2003 and is headquartered in Boston, MA. | Health Technology |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
- Bourse
- Insiders
- Geoffrey A. Swire
- Expérience